Home/Filings/4/0000875320-24-000091
4//SEC Filing

Sachdev Amit 4

Accession 0000875320-24-000091

CIK 0000875320other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 4:20 PM ET

Size

6.1 KB

Accession

0000875320-24-000091

Insider Transaction Report

Form 4
Period: 2024-02-21
Sachdev Amit
EVP Chief Patient & Ext Af Off
Transactions
  • Sale

    Common Stock

    2024-02-21$421.77/sh3,191$1,345,86860,798 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    882
  • Common Stock

    (indirect: By Trust)
    6,565
Footnotes (1)
  • [F1]Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2023.

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1
  • filerCIK 0001406338

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:20 PM ET
Size
6.1 KB